Literature DB >> 29160688

Novel Real-Time Proximity Assay for Characterizing Multiple Receptor Interactions on Living Cells.

Sina Bondza1,2, Hanna Björkelund2, Marika Nestor1, Karl Andersson1,2, Jos Buijs1,2.   

Abstract

Cellular receptor activity is often controlled through complex mechanisms involving interactions with multiple molecules, which can be soluble ligands and/or other cell surface molecules. In this study, we combine a fluorescence-based technology for real-time interaction analysis with fluorescence quenching to create a novel time-resolved proximity assay to study protein-receptor interactions on living cells. This assay extracts the binding kinetics and affinity for two proteins if they bind in proximity on the cell surface. One application of real-time proximity interaction analysis is to study relative levels of receptor dimerization. The method was primarily evaluated using the HER2 binding antibodies Trastuzumab and Pertuzumab and two EGFR binding antibodies including Cetuximab. Using Cetuximab and Trastuzumab, proximity of EGFR and HER2 was investigated before and after treatment of cells with the tyrosine-kinase inhibitor Gefitinib. Treated cells displayed 50% increased proximity signal, whereas the binding characteristics of the two antibodies were not significantly affected, implying an increase in the EGFR-HER2 dimer level. These results demonstrate that real-time proximity interaction analysis enables determination of the interaction rate constants and affinity of two ligands while simultaneously quantifying their relative colocalization on living cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29160688     DOI: 10.1021/acs.analchem.7b02983

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  2 in total

1.  Amplified fluorescence imaging of HER2 dimerization on cancer cells by using a co-localization triggered DNA nanoassembly.

Authors:  Tiantian Yang; Lulu Xu; Shengchun Liu; Yifan Shen; Lizhen Huang; Lutan Zhang; Shijia Ding; Wei Cheng
Journal:  Mikrochim Acta       Date:  2019-06-13       Impact factor: 5.833

2.  Bivalent binding on cells varies between anti-CD20 antibodies and is dose-dependent.

Authors:  Sina Bondza; Toine Ten Broeke; Marika Nestor; Jeanette H W Leusen; Jos Buijs
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.